The 2016 CNS WHO classification defines two groups: (1) isocitrate dehydrogenase (IDH)-wildtype (wt) glioblastoma and (2) IDH-mutant (mt) grade IV astrocytoma [1]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).